Addus HomeCare Corporation (ADUS) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Addus HomeCare Corporation stock $109, price $124, that is 12.0% below the price, quality 60 out of 100. Rating: overvalued. Calculated from audited financials with 22 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 6, 2026.
How to read this chart
60‑month range $70.43 – $135.92 · fair‑value band $74.61 – $138.48 · the $124.31 price screens above the $109.42 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 6, 2026.
Follow Addus HomeCare in your weekly email
Every Wednesday you see whether Addus HomeCare is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States.
Show moreShow less
The company operates through three segments: Personal Care, Hospice, and Home Health. Its Personal Care segment provides non-medical assistance with activities of daily living.
This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services.
The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families.
Its Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization.
The company serves federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is based in Frisco, Texas.
Stock analysis
Addus HomeCare Corporation (ADUS) currently trades at $124.31, while our model-based Fair Value estimate is $109.42, 12% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of $134.42 per share, and 7 of the 22 models we run sit above the $124.31 price.
Bear case: the Economic Profit group reads lowest at $59.16, and 15 of the 22 models stay below the price. Data coverage for this calculation is medium.
Scenario range: $74.61 (bear) to $138.48 (bull), the price of $124.31 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 60/100 (solid quality), in the Healthcare sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Addus HomeCare Corporation reported revenue of $1.4B in FY2025 versus $864M in FY2021, a compound +13.3%/yr. Reported net income was $95.9M in FY2025, compounding +20.7%/yr from FY2021.
Key figures
Market cap $2.3B Mid · P/E ratio 20.8 · P/S ratio 1.53 · EPS (TTM) $5.97 · Net margin 7.4% · Return on equity 10.0% · Return on assets (EBIT) 8.0% (5-year average) · Operating margin 10.3%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (medium confidence).
What moves the price
The share trades about 3% below its 52-week high and 40% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −1% fair-value upside, at −12%, ADUS screens richer than that median.
Fair Value models
Bear$74.61Fair Value $109.42Bull$138.48
Price $124.31 · Downside -12.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then ($5.10 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
In the last 6 months, 2 officers or directors sold shares worth $73,506 and none bought.
SaleHeather Brianne DixonPresident and Chief Operating288 shares at $93.77$27,006Jun 22, 202610b5-1 plan
SaleEsteban LopezDirector4× since Dec 5, 2025: 816 shares, avg. $101.10$82,499May 21, 2026
SaleCliff Donald BlessingEVP, Chief Development Officer3× since Feb 23, 2026: 1,076 shares, avg. $107.29$115,442Apr 21, 202610b5-1 plan
SaleMonica RainesEVP, CCO and Quality Officer3× since Feb 23, 2026: 1,326 shares, avg. $108.57$143,960Mar 2, 202610b5-1 plan
SaleR Dirk AllisonChairman and CEO, Director2× since Feb 23, 2026: 11,887 shares, avg. $109.68$1.3MFeb 25, 202610b5-1 plan
SaleBrian PoffEVP, Chief Financial Officer2× since Feb 23, 2026: 4,719 shares, avg. $109.82$518,244Feb 25, 202610b5-1 plan
SaleSean GaffneyEVP, Chief Legal Officer2× since Feb 23, 2026: 1,996 shares, avg. $109.55$218,660Feb 25, 202610b5-1 plan
SaleDarby AndersonEVP, Chief Govt Rel Officer3× since Nov 19, 2025: 21,795 shares, avg. $109.05$2.4MFeb 25, 2026
SaleDavid W. TuckerEVP, Chief Strategy Officer2× since Feb 23, 2026: 1,741 shares, avg. $109.77$191,117Feb 25, 202610b5-1 plan
SaleMichael D. WattenbargerEVP, Chief Information Officer2× since Feb 23, 2026: 1,469 shares, avg. $109.91$161,462Feb 25, 202610b5-1 plan
Plus 1 more entries from the last 12 months.
Plus 7 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.
Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.83/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+23.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+14.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+13.2%
Start year 2020 (pandemic). Over 10 years: +15.5% a year
Revenue growth 18 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+11.7%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: adjusted.
+19.5%
Earnings growth per share plus dividend.
Earnings per share, growth per year+19.5%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.20.1% vs 17.4%, steady
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.6% → 10%
Pace: the 5-year rate starts in 2020 (pandemic)
Growth Forecast
A lot of optimism in the price
The price assumes less growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+10.1%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+4.9%
Yearly sales growth analysts expect, extended to five years.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +7.5% a year for the price and +2.4% for the forecasts.
News mood ⓘNews mood, the average tone of recent news (100 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation.Hype
Recent news coverage is unusually upbeat, far more positive than stocks are typically covered.
Compare Addus HomeCare Corporation with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 233 stocks
Beats the industry median on 9/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score60 · Above median
Fair Value upside−12.0% · Below median
Profitability
Return on equity (12 months)10.0% · Above median
Return on assets6.7% · Above median
Net margin (12 months)7.4% · Above median
Operating margin (12 months)10.3% · Above median
Growth and dividend
Revenue growth (quarter YoY)7.0% · Above median
Balance sheet
Debt / equity0.11× · Below median
Valuation Multiplesvs Medical Care Facilities median · lower = cheaper
P/E (12 months)20.8× · Pricier than median
P/B2.12× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
P/S (12 months)1.53× · Cheaper than median
Price / free cash flow (fiscal year)22.1× · Pricier than median
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Addus HomeCare Corporation (ADUS) overvalued or undervalued?
As of Nov 6, 2026, our model estimates a fair value of $109.42 versus a price of $124.31, about 12% lower (overvalued).
What is the fair value of ADUS?
Our model-based fair value for Addus HomeCare Corporation is $109.42 (as of Nov 6, 2026), built from audited fundamentals. The current price: $124.31.
What is the quality score of ADUS?
Addus HomeCare Corporation has a Quality Score of 60/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Addus HomeCare Corporation (ADUS)?
Our model-based price target is the fair value of $109.42 (as of Nov 6, 2026) from 22 valuation models. Cautious scenario $74.61, optimistic scenario $138.48. It is a calculation from audited fundamentals, not an analyst target.
What is the Addus HomeCare Corporation stock forecast for 2026?
Our models put fair value at $109.42, about 12% lower versus a price of $124.31 (overvalued). Cautious scenario $74.61, optimistic scenario $138.48. The calculation is refreshed regularly with new filings.
What is the revenue of Addus HomeCare Corporation (ADUS)?
Addus HomeCare Corporation reported trailing-twelve-month revenue of about $1.5B (latest available figure, as of Nov 6, 2026).
What growth is priced into Addus HomeCare Corporation (ADUS)?
For today's price to be fair in a discounted-cash-flow model, Addus HomeCare Corporation would have to grow free cash flow by +10.1 % per year for five years (discount rate 9.1 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +13.2 % per year. As of Nov 6, 2026.
What discount rate (WACC) does the fair value of ADUS use?
Our models discount Addus HomeCare Corporation at 9.1 %: a base by market capitalisation (mid), damped by beta 0.74, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Addus HomeCare Corporation that is +10.1 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (9.1 %) and the same formula as our fair value.
How much growth has Addus HomeCare Corporation (ADUS) delivered so far?
Over the past 5 years revenue at Addus HomeCare Corporation grew +13.2 % a year. The price currently implies free-cash-flow growth of +10.1 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Addus HomeCare Corporation (ADUS) growing?
The median revenue growth in the sector is +6.2 % a year. That is the yardstick for the growth priced into Addus HomeCare Corporation (+10.1 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Addus HomeCare Corporation (ADUS)?
The free-cash-flow yield on the price is 4.52 %: that much free cash flow Addus HomeCare Corporation produces per unit of market value. When it exceeds the discount rate of our models (9.1 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Addus HomeCare Corporation (ADUS)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Addus HomeCare Corporation it is $109.42 per share (as of Nov 6, 2026), against a price of $124.31. It is the blended result of 22 valuation models in 6 families (DCF Models, Earnings-Based, Multiples, Growth DCF, Economic Profit, Growth Earnings).
Is Addus HomeCare Corporation stock overvalued or undervalued in 2026?
As of Nov 6, 2026, ADUS trades above its calculated fair value: price $124.31, fair value $109.42, a gap of about −12% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of ADUS?
No. The price is what the market pays today ($124.31); the fair value is what the company's own numbers justify ($109.42). For Addus HomeCare Corporation the two are $14.89 per share apart. That gap is exactly why we show both numbers side by side.
How much is Addus HomeCare Corporation worth?
The market values Addus HomeCare Corporation at about $2.3B (market capitalisation, as of Nov 6, 2026). Per share that is $124.31; our models calculate a fair value of $109.42 per share.
What do the bullish and bearish scenarios say about ADUS?
Our models span a range for Addus HomeCare Corporation: cautious scenario $74.61, base $109.42, optimistic $138.48 per share (as of Nov 6, 2026, price $124.31). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of ADUS?
Addus HomeCare Corporation trades at a price-to-earnings ratio of 20.8 (as of Nov 6, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $109.42 is built from several models across several years. Median P/E at fiscal year-end, 10 fiscal years (2016 to 2025), reported earnings, 6 of the years ex one-offs: 33.0. Other multiples: PEG 1.1, P/B 2.1, P/S 1.5, EV/EBITDA 13.5.
What is the PEG ratio of ADUS?
The PEG ratio of Addus HomeCare Corporation is 1.10 (P/E divided by earnings growth, as of Nov 6, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Addus HomeCare Corporation (ADUS)?
Balance-sheet figures for Addus HomeCare Corporation (as of Nov 6, 2026): return on equity 10.0%, debt of 0.11 per unit of equity. They feed the Quality Score of 60/100, which measures business quality independently of the share price.
How far is ADUS from its 52-week high?
Addus HomeCare Corporation trades at $124.31, about 3% below its 52-week high of $127.94 and 40% above the low of $88.49 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of $109.42 is for.
Which stocks are comparable to Addus HomeCare Corporation?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Tenet Healthcare Corporation, Dr. Sulaiman Al Habib Medical Services Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Addus HomeCare Corporation stock attractive at the current price?
The data as of Nov 6, 2026: price $124.31, calculated fair value $109.42 (−12%), Quality Score 60/100, from 22 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of ADUS calculated?
We run Addus HomeCare Corporation through 22 models from 6 families: DCF Models, Earnings-Based, Multiples, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of $109.42 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0% above its aggregate fair value. Addus HomeCare Corporation itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Addus HomeCare Corporation (ADUS)?
The closing price on Nov 6, 2026 was $124.31. Our model-based fair value is $109.42, about 12% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Addus HomeCare Corporation right now?
A fairly wide model range ($74.61 to $138.48) leaves room in how you read the outcome. The price sits in the upper half of our model range, so the margin of safety is thin. Read the verdict with care: some models are missing inputs, so the estimate scatters more than usual.
Where does the earnings growth of Addus HomeCare Corporation (ADUS) come from?
Earnings per share at Addus HomeCare Corporation grew +17.3 % a year from 2014 to 2025. Broken into its drivers: revenue per share +9.4 %, EBIT margin +7.6 %, tax rate +0.4 %, residual (interest, one-offs) −0.8 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Addus HomeCare Corporation
How large is the market capitalisation of Addus HomeCare Corporation (ADUS)?
The market capitalisation of Addus HomeCare Corporation is $2.3B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Addus HomeCare Corporation (ADUS)?
The price-to-sales ratio of Addus HomeCare Corporation is 1.53 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Addus HomeCare Corporation (ADUS)?
Earnings per share at Addus HomeCare Corporation are $5.97 (price ÷ EPS = P/E 20.8). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Addus HomeCare Corporation (ADUS)?
The net margin of Addus HomeCare Corporation is 7.4% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Addus HomeCare Corporation (ADUS)?
The return on equity (ROE) of Addus HomeCare Corporation is 10.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Addus HomeCare Corporation (ADUS)?
On an EBIT basis the return on assets of Addus HomeCare Corporation is 8.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Addus HomeCare Corporation (ADUS)?
The operating margin of Addus HomeCare Corporation is 10.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Addus HomeCare Corporation (ADUS)?
Revenue at Addus HomeCare Corporation is growing +7.0% versus a year earlier (3y avg +14.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Addus HomeCare Corporation (ADUS)?
Earnings per share at Addus HomeCare Corporation are growing +24.2% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Addus HomeCare Corporation (ADUS) carry?
The net debt of Addus HomeCare Corporation is $127M (fiscal year 2025, ≈ 1.2 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Addus HomeCare Corporation in the live analysis
One click puts Addus HomeCare Corporation on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Some data
Nov 6, 2026